Riskpilot← Back to searchSign inGet full accessPOLYBOS AS
ASActiveOrg 995928825Tørfestveien 8, 3124 TønsbergOther human health activities n.e.c. · NACE 8699Est. 20102 employees
Revenue 2024
NOK 2,8M
+1% vs 2023
EBITDA margin
12.4%
-37% vs 2023
Equity ratio
64.0%
Financial strength
Net profit 2024
NOK 315K
-31% vs 2023
| Revenue | NOK 2,8M | +1% |
| EBITDA | NOK 344K | -37% |
| Net profit | NOK 315K | -31% |
| Total assets | NOK 2,2M | +19% |
| Equity | NOK 1,4M | +28% |
| Employees | 2 | — |
Legal name
POLYBOS AS
Org number
995928825
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
23. oktober 2010
Share capital
NOK 100 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Eie og drive virksomhet innen fagområdet medisin, knyttet til formidling av kunnskap og tjenesteyting innen dette fagområdet samt virksomhet som står i naturlig sammenheng med dette, herunder å delta i andre selskaper med samme formål.
Address
Tørfestveien 8, 3124 Tønsberg
Phone
+4745287260
Email
bb@polybo.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 1 031 | 1 722 | 589 | 1 263 | 1 206 | 1 292 | 1 533 | 1 493 | 2 216 | 1 682 | 1 589 | 1 733 | 2 738 | 2 779 |
| Staff expenses | −0 | −22 | −1 645 | −703 | −1 017 | −623 | −663 | −912 | −1 172 | −1 185 | −1 338 | −1 486 | −1 449 | −1 844 | −2 029 |
| EBITDA | 0 | 986 | 32 | −294 | −138 | −72 | −530 | 240 | 6 | 842 | 141 | −114 | 78 | 547 | 344 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −51 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −0 |
| EBIT | 0 | 986 | 32 | −294 | −138 | −72 | −581 | 240 | 6 | 842 | 141 | −114 | 78 | 547 | 344 |
| Net financials | 0 | 4 | −81 | 1 | −75 | −15 | −2 | 16 | 0 | 0 | −1 | 1 | 1 | 24 | 62 |
| Profit before tax | 0 | 990 | −50 | −293 | −213 | −87 | −583 | 256 | 6 | 842 | 140 | −114 | 79 | 571 | 405 |
| Tax | −0 | 277 | −0 | −0 | −0 | −0 | −0 | −0 | −0 | 151 | 30 | −0 | −0 | 114 | 90 |
| Net profit | 0 | 713 | −50 | −293 | −213 | −87 | −583 | 256 | 6 | 691 | 110 | −114 | 79 | 457 | 315 |
| Item | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 100 | 1 096 | 1 114 | 1 247 | 900 | 1 105 | 498 | 701 | 571 | 1 003 | 1 050 | 857 | 985 | 1 869 | 2 230 |
| Equity | 100 | 813 | 704 | 411 | 198 | 110 | −705 | −116 | −110 | 581 | 691 | 577 | 656 | 1 113 | 1 428 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 63 | 63 | 0 | 0 | 0 | 225 | 224 |
| Short-term debt | 0 | 283 | 410 | 836 | 702 | 995 | 1 202 | 817 | 617 | 358 | 359 | 280 | 329 | 531 | 577 |
| Total debt | 0 | 283 | 410 | 836 | 702 | 995 | 1 202 | 817 | 681 | 422 | 359 | 280 | 329 | 756 | 802 |
EBITDA margin
12.4%
This company
15.8%
Market median
-22% vs market
20102024
Equity ratio
64.0%
This company
38.2%
Market median
+68% vs market
20102024
Return on equity
22.1%
This company
18.4%
Market median
+20% vs market
20102024
Net profit margin
11.4%
This company
8.1%
Market median
+41% vs market
20102024
Asset turnover
1.25×
This company
1.12×
Market median
+12% vs market
20102024
Debt / equity
0.56×
This company
0.62×
Market median
+10% vs market
20102024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
SH Deputy Member | Deputy Member | 2010 | — | — |
EH Chief Executive Officer | Chief Executive Officer | 2010 | — | — |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
POLYBOS AS 
Dr. Hexebergs Klinikk AsBoard members of POLYBOS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sofie Hexeberg | Deputy Member | 0 companies |
| Erik Hexeberg | Chief Executive Officer | 0 companies |